These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 33601152)

  • 41. Role of non-coding RNAs mediated pyroptosis on cancer therapy: a review.
    Zhao D; Wu T; Tan Z; Xu J; Lu Z
    Expert Rev Anticancer Ther; 2024 May; 24(5):239-251. PubMed ID: 38594965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging roles of long non-coding RNAs in breast cancer biology and management.
    Amelio I; Bernassola F; Candi E
    Semin Cancer Biol; 2021 Jul; 72():36-45. PubMed ID: 32619506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-coding RNAs as regulators of mammary development and breast cancer.
    Piao HL; Ma L
    J Mammary Gland Biol Neoplasia; 2012 Mar; 17(1):33-42. PubMed ID: 22350981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The emerging regulatory roles of non-coding RNAs associated with glucose metabolism in breast cancer.
    Kansara S; Singh A; Badal AK; Rani R; Baligar P; Garg M; Pandey AK
    Semin Cancer Biol; 2023 Oct; 95():1-12. PubMed ID: 37364663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long non-coding RNAs as prognostic markers in human breast cancer.
    Liu H; Li J; Koirala P; Ding X; Chen B; Wang Y; Wang Z; Wang C; Zhang X; Mo YY
    Oncotarget; 2016 Apr; 7(15):20584-96. PubMed ID: 26942882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancer.
    Pecero ML; Salvador-Bofill J; Molina-Pinelo S
    Cell Oncol (Dordr); 2019 Feb; 42(1):1-12. PubMed ID: 30361825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The emerging role of long noncoding RNAs in oral cancer.
    Gomes CC; de Sousa SF; Calin GA; Gomez RS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Feb; 123(2):235-241. PubMed ID: 27989708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
    Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
    Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decoding the usefulness of non-coding RNAs as breast cancer markers.
    Amorim M; Salta S; Henrique R; Jerónimo C
    J Transl Med; 2016 Sep; 14():265. PubMed ID: 27629831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNAs in the diagnosis and prognosis of breast cancer and their therapeutic potential (review).
    Zhang K; Zhang Y; Liu C; Xiong Y; Zhang J
    Int J Oncol; 2014 Sep; 45(3):950-8. PubMed ID: 24913679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comprehensive analysis of the aberrantly expressed lncRNA‑associated ceRNA network in breast cancer.
    Tuersong T; Li L; Abulaiti Z; Feng S
    Mol Med Rep; 2019 Jun; 19(6):4697-4710. PubMed ID: 31059025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epigenomics-based identification of oestrogen-regulated long noncoding RNAs in ER+ breast cancer.
    Zhang Z; Yu W; Tang D; Zhou Y; Bi M; Wang H; Zheng Y; Chen M; Li L; Xu X; Zhang W; Tao H; Jin VX; Liu Z; Chen L
    RNA Biol; 2020 Nov; 17(11):1590-1602. PubMed ID: 32506995
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-coding RNAs, guardians of the p53 galaxy.
    Chen S; Thorne RF; Zhang XD; Wu M; Liu L
    Semin Cancer Biol; 2021 Oct; 75():72-83. PubMed ID: 32927018
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-coding RNAs, another side of immune regulation during triple-negative breast cancer.
    Alghazali MW; Al-Hetty HRAK; Ali ZMM; Saleh MM; Suleiman AA; Jalil AT
    Pathol Res Pract; 2022 Nov; 239():154132. PubMed ID: 36183439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma.
    Ren K; Ni Y; Li X; Wang C; Chang Q; Li Y; Gao Z; Wu S; Shi X; Song J; Yao N; Zhou J
    J Cell Biochem; 2019 Aug; 120(8):12473-12488. PubMed ID: 30825232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interplay between LncRNAs and microRNAs in Breast Cancer.
    Schwarzenbach H; Gahan PB
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application.
    Zhang L; Xu X; Su X
    Mol Cancer; 2020 Mar; 19(1):48. PubMed ID: 32122338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of non-coding RNAs as novel biomarkers for detection of colorectal cancer progression through interaction with the cell signaling pathways.
    Esmaeili M; Keshani M; Vakilian M; Esmaeili M; Peymani M; Seyed Forootan F; Chau TL; Göktuna SI; Zaker SR; Nasr Esfahani MH; Ghaedi K
    Gene; 2020 Aug; 753():144796. PubMed ID: 32450203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long non-coding RNAs involved in metastasis of gastric cancer.
    Lin MT; Song HJ; Ding XY
    World J Gastroenterol; 2018 Sep; 24(33):3724-3737. PubMed ID: 30197478
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insights into the roles of non-coding RNAs and angiogenesis in glioblastoma: An overview of current research and future perspectives.
    Song Z; Xue Z; Wang Y; Imran M; Assiri M; Fahad S
    Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130567. PubMed ID: 38242182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.